Company Registration No. 06451324 (England and Wales)
UME DIAGNOSTIC MANAGEMENT COMPANY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
Star House
Star Hill
Rochester
Kent
ME1 1UX
UME DIAGNOSTIC MANAGEMENT COMPANY LIMITED
CONTENTS
Page
Company information
1
Statement of financial position
2 - 3
Notes to the financial statements
4 - 5
UME DIAGNOSTIC MANAGEMENT COMPANY LIMITED
COMPANY INFORMATION
- 1 -
Director
Mr S Khoury
Company number
06451324
Registered office
17 Harley Street
Marylebone
London
W1G 9QH
Accountants
TC Group
Star House
Star Hill
Rochester
Kent
ME1 1UX
Bankers
HSBC Bank Plc
9 The Boulevard
Crawley
West Sussex
RH10 1UT
Solicitors
Field Fisher Waterhouse
35 Vine Street
London
EC3N 1UT
UME DIAGNOSTIC MANAGEMENT COMPANY LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 DECEMBER 2025
31 December 2025
- 2 -
2025
2024
Notes
£
£
£
£
Fixed assets
Investment property
3
400,000
400,000
Current assets
Debtors
4
-
0
16
Cash at bank and in hand
211
273
211
289
Creditors: amounts falling due within one year
5
(9,384)
(9,011)
Net current liabilities
(9,173)
(8,722)
Net assets
390,827
391,278
Capital and reserves
Called up share capital
1,000,000
1,000,000
Revaluation reserve
50,000
50,000
Profit and loss reserves
(659,173)
(658,722)
Total equity
390,827
391,278

The director of the company has elected not to include a copy of the income statement within the financial statements.true

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

UME DIAGNOSTIC MANAGEMENT COMPANY LIMITED
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT
31 DECEMBER 2025
31 December 2025
- 3 -
The financial statements were approved and signed by the director and authorised for issue on 4 June 2026
Mr S Khoury
Director
Company registration number 06451324 (England and Wales)
UME DIAGNOSTIC MANAGEMENT COMPANY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 4 -
1
Accounting policies
Company information

UME Diagnostic Management Company Limited is a private company limited by shares incorporated in England and Wales. The registered office is 17 Harley Street, Marylebone, London, W1G 9QH.

1.1
Accounting convention

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

 

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

 

The financial statements have been prepared under the historical cost convention. The principal accounting policies are set out below:

1.2
Going concern

The Directors have decided to close the company after the land has been sold. The financial statements therefore are prepared on a basis other than going concern, which includes, where appropriate, writing down the Company assets to net realisable value. The financial statements do not include any provision for future costs of terminating the activities of the Company except to the extent that such costs were committed at the balance sheet date.

1.3
Investment properties

Investment property is carried at fair value, which is determined annually using a desktop valuation. No depreciation is provided. Changes in fair value are recognised in the Statement of Comprehensive Income.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
1
1
UME DIAGNOSTIC MANAGEMENT COMPANY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 5 -
3
Investment property
2025
£
Fair value
At 1 January 2025 and 31 December 2025
400,000

The investment property is valued by a directors valuation at market value.

4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
-
0
16
5
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
-
0
96
Amounts owed to group undertakings
3,729
2,335
Accruals and deferred income
5,655
6,580
9,384
9,011
6
Parent company

The Company's immediate parent undertaking is UME Investment Co. Limited, a company incorporated in England and Wales.

 

The smallest group in which the results of the LLP are consolidated is that headed by United Medical Enterprises Group LLP. Copies of United Medical Enterprises Group LLP financial statements are available from Companies House, Crown Way, Cardiff, CF14 3UZ.

 

The ultimate parent is United Medical Enterprises Group Limited (BC 343764), incorporated in the British Virgin Islands. This company is the largest group in which the results of the company are consolidated.

2025-12-312025-01-01falsefalsefalse09 June 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMr S Khoury064513242025-01-012025-12-3106451324bus:Director12025-01-012025-12-3106451324bus:RegisteredOffice2025-01-012025-12-3106451324bus:Agent12025-01-012025-12-31064513242025-12-31064513242024-12-3106451324core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3106451324core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3106451324core:ShareCapital2025-12-3106451324core:ShareCapital2024-12-3106451324core:RevaluationReserve2025-12-3106451324core:RevaluationReserve2024-12-3106451324core:RetainedEarningsAccumulatedLosses2025-12-3106451324core:RetainedEarningsAccumulatedLosses2024-12-31064513242024-01-012024-12-31064513242024-12-3106451324core:CurrentFinancialInstruments2025-12-3106451324core:CurrentFinancialInstruments2024-12-3106451324bus:PrivateLimitedCompanyLtd2025-01-012025-12-3106451324bus:SmallCompaniesRegimeForAccounts2025-01-012025-12-3106451324bus:FRS1022025-01-012025-12-3106451324bus:AuditExemptWithAccountantsReport2025-01-012025-12-3106451324bus:FullAccounts2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP